Local News: Kahuku, HI 

 | 

Sign Up

 | 

Sign In

Advertisment

Zetia, Ezetimibe News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Zetia, Ezetimibe News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Zetia, Ezetimibe News

News on Zetia, Ezetimibe (generic) continually updated from thousands of sources around the net.

Tuesday | Bloomberg

Merck Cholesterol Pill Sales May Decline 20% More on Third Negative Study

Merck & Co. may face a third negative study result within two years for its cholesterol pills Vytorin and Zetia, which have lost 14 percent of sales since January and could sink further.

Comment?

Related Topix: Medicine, Cholesterol, Health, Biotech, Merck , Healthcare Industry, Medication, Niacin (generic), Niaspan, Niacor, Abbott Laboratories, Cardiology

Thu Nov 05, 2009

BNET

Amateur Hour at Merck: FDA Refuses to Look at Zetia-Lipitor Combo Pill

Merck was sent back to the drawing board on its new Zetia-Lipitor combo drug when the FDA refused to accept its application.

Comment?

Related Topix: Medication, Medicine, Lipitor, Atorvastatin (generic), Zocor, Simvastatin (generic), Cholesterol, Health

Wed Nov 04, 2009

Bioscience Technology

1310States:NJ,NY,BA; US:DSF; Intl:; Fmts:Print, Online, Broadcast;...

Merck disclosed the rare move by the Food and Drug Administration in a regulatory filing Monday.

Comment?

Related Topix: Medicine, Cholesterol, Health, Lipitor, Atorvastatin (generic), Medication, Food and Drug Administration, Schering Plough, Biotech, Healthcare Industry, Whitehouse Station, NJ

SouthCoastToday.com

Heart valve changes don't always warrant treatment

DEAR DR. DONOHUE: I had been feeling slightly uncomfortable in my chest, especially in the morning after waking.

Comment?

Related Topix: Medication, Medicine, Cholesterol, Health, Zocor, Simvastatin (generic)

Tue Nov 03, 2009

MarketNewsVideo

FDA Turns Down Combination Cholesterol Drug Pill Application

The two companies have been partners on cholesterol drugs since 2000, and the new pill was expected to be a blockbuster.

Comment?

Related Topix: Medicine, Cholesterol, Health, Medication, Business News, Video

Mon Nov 02, 2009

Chicago Tribune

Merck: FDA won't accept its application for combo cholesterol pill including Pfizer's Lipitor

In this May 22, 2008 file photo, the company logo is seen on the doors of a building at Merck & Co.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Food and Drug Administration, Cholesterol, Health, Lipitor, Atorvastatin (generic), Medication, Whitehouse Station, NJ

Thu Oct 29, 2009

Medical News Today

Ezetimibe Makes Atorvastatin More Efficient In Lowering Lipids In Men And Women Age 65 And Older

Main Category: Heart Disease Also Included In: Statins ; Cholesterol ; Seniors / Aging Article Date: 29 Oct 2009 - 0:00 PDT printer friendly view / write opinions rate article Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and ...

Comment?

Related Topix: Medicine, Lipitor, Atorvastatin (generic), Medication, Cholesterol

Tue Oct 27, 2009

EurekAlert!

Adding ezetimibe to atorvastatin improves lipid control

Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr.

Comment?

Related Topix: Medicine, Lipitor, Atorvastatin (generic), Medication, Stroke, Health, Cholesterol

Thu Oct 22, 2009

Zacks Analyst Blog

Schering-Plough Reports In-line

Analyst Report ) reported third-quarter earnings of 40 cents per share, which was in-line with the Zacks Consensus Estimate.

Comment?

Related Topix: 9, Medicine, Cholesterol, Health, Medication, Zocor, Simvastatin (generic), Crohn's Disease

Mon Oct 12, 2009

Lipids in Health and Disease

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia

Ezetimibe is a potent inhibitor of cholesterol absorption that has been approved for the treatment of hypercholesterolemia.

Comment?

Related Topix: Medication

Sun Oct 11, 2009

PharmaGossip

SchMerk - Vytorin: call the confidential informant

Plaintiffs believe that after a reasonable opportunity for further investigation and discovery, the evidence will show that Defendants were aware in.

Comment?

Related Topix: Medication

Fri Sep 18, 2009

Miami Herald

Sanofi buys Merck's half of animal health business

Merck & Co. is buying Schering-Plough for $41.1 billion in a deal that gives Merck key new businesses, access to a promising pipeline of new products and the chance to further cut costs, including eliminating about 16,000 jobs.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Schering Plough, Asthma, Health, Medication, Advanced Micro Devices, Semiconductors, Startups

Sat Sep 05, 2009

Canada.com

Food, not pills, best lowers cholesterol

Salmon is high in omega-3 fatty acids which may lower cholesterol. There is little evidence to support the widespread use of so-called "combination therapies" to lower cholesterol, according to experts from the Ottawa Hospital Research Institute and the University of Ottawa.

Comment?

Related Topix: Niacin (generic), Niaspan, Niacor, Medicine, Medication

Thu Sep 03, 2009

BioSpace

Statins May Perform Better as a Solo Act, Study

High-dose statin monotherapy generally reduces cholesterol as well as combining a statin with another drug, although there is some evidence that a statin combined with ezetimibe in high-risk patients is slightly more effective than statins alone, a systematic review has shown.

Comment?

Related Topix: Medication

Wed Sep 02, 2009

WOIO

Combo Therapies to Lower Cholesterol Don't Work

Despite their popularity, so-called "combination therapies" may not be the most effective treatment for high cholesterol, Canadian researchers report.

Comment?

Related Topix: Cholesterol, Medicine, Health, Medication, Niacin (generic), Niaspan, Niacor

Journal Watch - Medicine that Matters

Combination Lipid-Lowering Therapy May Not Be More Effective Than High-Dose Statin Monotherapy

"Limited evidence" suggests that combination lipid-lowering therapy is no more effective than high-dose statin monotherapy for improving clinical outcomes, according to a meta-analysis published online in Annals of Internal Medicine .

Comment?

Related Topix: Medication

Tue Sep 01, 2009

Circulation

Letter by Tershakovec et al Regarding Article, "Evidence for Statin...

The article in Circulation by Liu et al1 claims that statin monotherapy provides greater "pleiotropic effects" than low-dose statin with ezetimibe due to the effects on Rho-kinase activity, which is postulated to play a role in flow-mediated dilation , a surrogate marker for endothelial function.

Comment?

Related Topix: Medication

Mon Aug 17, 2009

Daily Herald

10 ways to lower your cholesterol level

Your doctor tells you that your level of LDL - the "bad" type of cholesterol - is too high, and, in a double whammy, he says that your level of HDL - the "good" cholesterol - is too low.

Comment?

Related Topix: Medicine, Cholesterol, Health, University of Colorado Denver, Medication

Thu Aug 13, 2009

New England Journal of Medicine

Premature Release of Data from Clinical Trials of Ezetimibe

Robert M. Califf, M.D., Robert A. Harrington, M.D., and Michael A. Blazing, M.D. The recent controversy about whether the cholesterol-lowering drug ezetimibe causes cancer raises urgent questions about the systems we use to develop drugs and medical devices and then to evaluate their safety and effectiveness.1,2,3 There is widespread recognition ...

Comment?

Related Topix: Medication

Wed Aug 12, 2009

TulsaWorld.com - Business

Merck, Schering-Plough settle Vytorin lawsuits

Drug developers Merck & Co. and Schering-Plough Corp. said Wednesday they will pay $41.5 million to settle a series of lawsuits claiming they delayed key study results on their cholesterol drug Vytorin because the data was unfavorable.

Comment?

Related Topix: Schering Plough, Biotech, Medicine, Healthcare Industry, Merck , Cholesterol, Health, Medication, Zocor, Simvastatin (generic)

Also on Topix